1-3 of 3
Jörg Westermann
Close
Sort by
Journal Articles

AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology

Marius-Konstantin Klever, Eric Sträng, Sara Hetzel, Julius Jungnitsch, Anna Dolnik, Robert Schöpflin, Jens-Florian Schrezenmeier, Felix Schick, Olga Blau, Jörg Westermann, Frank G. Rücker, Zuyao Xia, Konstanze Döhner, Hubert Schrezenmeier, Malte Spielmann, Alexander Meissner, Uirá Souto Melo, Stefan Mundlos, Lars Bullinger
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6520–6531.
https://doi.org/10.1182/bloodadvances.2023010887
Published: 2023
Includes: Supplemental data
Journal Articles

Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications

Clinical Trials & Observations
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut Salih, Michael Lübbert, Michael W. M. Kühn, Thomas Schroeder, Hans Salwender, Katharina Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I. Gaidzik, Frauke Theis, Felicitas Thol, Michael Heuser, Richard F. Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Richard Larson, Richard Stone, Konstanze Döhner, Arnold Ganser
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5345–5355.
https://doi.org/10.1182/bloodadvances.2022007223
Published: 2022
Includes: Supplemental data
Journal Articles

BCR-ABL + acute myeloid leukemia: are we always dealing with a high-risk disease?

Nina Rosa Neuendorff, Philipp Hemmati, Renate Arnold, Jana Ihlow, Bernd Dörken, Carsten Müller-Tidow, Jörg Westermann
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1409–1411.
https://doi.org/10.1182/bloodadvances.2018015594
Published: 2018